Clinical Trial

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

Name: A Study Assessing KB407 for the Treatment of Cystic Fibrosis — clinical trial record (NCT05504837)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study will evaluate safety and tolerability of ascending doses of nebulized KB407 in adults with cystic fibrosis.

Protocol Amendment History 8 amendments

This ClinicalTrials.gov record has been amended 8 times since 2022-08-15; most recent amendment 2026-05-01.

Status change: Not Yet Recruiting → Recruiting 2023-06-01

Trial Details

NCT Number	NCT05504837
Lead Sponsor	Krystal Biotech, Inc.
Conditions	Cystic Fibrosis
Enrollment	20 participants
Start Date	2023-06-30
Primary Completion	2026-12 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-05-07